Roivant · 2 days ago
VP/Director of Payer Growth
Roivant is a biopharmaceutical company that aims to improve the lives of patients by accelerating the development and commercialization of medicines that matter. They are seeking a VP or Director of Payer Growth to drive new sales and partnerships with health plans/payers across existing Roivant Health incubations, focusing on market penetration of innovative healthcare technology Vants.
BiopharmaBiotechnologyHealth CarePharmaceuticalProduct Research
Responsibilities
Lead sales and partnership efforts with national and regional payers across lines of business to drive adoption and scale for Roivant Health’s portfolio companies
Drive go-to-market strategy and implementation, including both hands-on lead generation and high-level sales motions to support the entire sales pipeline through to contracting
Support the development and execution of value-based care strategies and contracts in collaboration with Roivant Health and Vant leadership
Collaborate closely with the leadership teams of individual Roivant Health Vants to understand their specific needs and tailor business development approaches for optimal market fit and growth
Provide market insights from the payer landscape back to Roivant Health's incubation teams to inform product development and go-to-market strategies
Qualification
Required
Exceptional academic background
Proven track record of successfully signing new payer and strategic partnerships within a fast-paced healthcare technology and/or services company
Deep familiarity with the health insurance ecosystem, including an in-depth understanding of strategic priorities, operational challenges, governance structures, and contracting mechanisms
Detailed experience in a specific geography, market or lines of business is welcomed though not essential
Demonstrated ability to operate independently and entrepreneurially in a fast-paced environment
Excellent strategic, communication, and execution skills
Strong business development, negotiation, and relationship management skills are highly valued
Benefits
Discretionary bonuses
Company-sponsored benefit programs
Company
Roivant
Roivant aims to improve health by rapidly delivering innovative medicines and technologies to patients.
Funding
Current Stage
Public CompanyTotal Funding
$2.47BKey Investors
SoftBank Vision FundViking Global InvestorsQVT Financial
2023-02-02Post Ipo Equity· $230M
2022-11-08Post Ipo Equity· $150M
2021-10-01Post Ipo Equity· $200M
Recent News
MarketScreener
2026-01-03
MarketScreener
2025-12-19
MarketScreener
2025-12-18
Company data provided by crunchbase